BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9045459)

  • 1. [Antithrombin III in the treatment of disseminated intravascular coagulation].
    Nordgaard-Andersen I; Madsen JR
    Ugeskr Laeger; 1997 Feb; 159(6):730-1. PubMed ID: 9045459
    [No Abstract]   [Full Text] [Related]  

  • 2. Epilogue: disseminated intravascular coagulation and antithrombin III in intensive care medicine: pathophysiological insights and therapeutic hopes.
    Schuster HP
    Semin Thromb Hemost; 1998; 24(1):81-3. PubMed ID: 9515783
    [No Abstract]   [Full Text] [Related]  

  • 3. The use of antithrombin III (ATIII) for disseminated intravascular coagulation (DIC) during septic shock.
    Cohendy R; Lefrant JY; de la Coussaye JE
    Intensive Care Med; 1998 Dec; 24(12):1344. PubMed ID: 9885894
    [No Abstract]   [Full Text] [Related]  

  • 4. High dose of intravenous antithrombin III without heparin in the treatment of disseminated intravascular coagulation and organ failure in four children.
    Fuse S; Tomita H; Yoshida M; Hori T; Igarashi C; Fujita S
    Am J Hematol; 1996 Sep; 53(1):18-21. PubMed ID: 8813091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evidence-based medicine and disseminated intravascular coagulation (DIC)].
    Skadborg MK
    Ugeskr Laeger; 1997 May; 159(21):3189-90. PubMed ID: 9199010
    [No Abstract]   [Full Text] [Related]  

  • 6. Antithrombin (AT) substitution: sense or nonsense?
    Köhler M
    Anaesthesia; 1998 May; 53 Suppl 2():52-4. PubMed ID: 9659067
    [No Abstract]   [Full Text] [Related]  

  • 7. The anti-inflammatory properties of antithrombin III: new therapeutic implications.
    Okajima K; Uchiba M
    Semin Thromb Hemost; 1998; 24(1):27-32. PubMed ID: 9515777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Are there certified indications for the use of antithrombin III in intensive care].
    Kulka PJ; Tryba M; Lange S
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2001 Mar; 36(3):143-53. PubMed ID: 11324345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current views on the therapeutic use of heparin and antithrombin III in disseminated intravascular coagulation].
    Sobczyk J; Swietliński J; Podleśny-Owsińska T
    Pol Tyg Lek; 1989 Oct 2-16; 44(40-42):896-8. PubMed ID: 2487947
    [No Abstract]   [Full Text] [Related]  

  • 10. Antithrombin III in Sepsis. New evidences and open questions.
    Ostermann H
    Minerva Anestesiol; 2002 May; 68(5):445-8. PubMed ID: 12029261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Place of antithrombin III concentrate in the intensive care of disseminated intravascular coagulation].
    Vorob'eva NA; Neporada EL; Turundaevskaia OV; Mel'nikova GN
    Anesteziol Reanimatol; 2007; (2):42-4. PubMed ID: 17563999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences between functional and immunologic determinations of plasma antithrombin during the treatment of disseminated intravascular coagulation by infusion of antithrombin III concentrate.
    Jespersen J; Rasmussen NR; Sidelmann J
    Acta Chir Scand Suppl; 1982; 509():105-7. PubMed ID: 6962611
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapeutic use of antithrombin III in shock and disseminated intravascular coagulation.
    Vinazzer H
    Semin Thromb Hemost; 1989 Jul; 15(3):347-52. PubMed ID: 2688106
    [No Abstract]   [Full Text] [Related]  

  • 14. Antithrombin III concentrates for treatment of disseminated intravascular coagulation in children.
    Hanada T; Abe T; Takita H
    Am J Pediatr Hematol Oncol; 1985; 7(1):3-8. PubMed ID: 4037242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Purpura fulminans in the newborn. Report of two cases successfully treated with heparin and antithrombin III].
    Ficuccilli F; Iacobini M; Beglieri MR; Papoff P; Mancuso M; Caradonna A; Donato AI; Colarizi P
    Minerva Pediatr; 1997 Dec; 49(12):571-7. PubMed ID: 9577159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous administration of antithrombin III and protein C concentrates for the treatment of a devastating coagulopathy in a child.
    Favier R; Deschamps A; Belhocine R; Ankri A; Costil J; de Moerloose P
    Hematol Cell Ther; 1998 Apr; 40(2):67-70. PubMed ID: 9615249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the usefulness of antithrombin-III in the management of disseminated intravascular coagulation in obstetrically Ill patients.
    Kobayashi A; Matsuda Y; Mitani M; Makino Y; Ohta H
    Clin Appl Thromb Hemost; 2010 Dec; 16(6):688-93. PubMed ID: 19833617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of DIC with a serine proteinase inhibitor.
    Yokota T; Yamada Y; Takahashi M; Kunii Y; Iwamoto K; Kagami M; Kikuchi S; Yamauchi H; Yoshikawa K
    Am J Emerg Med; 2001 Jul; 19(4):334-5. PubMed ID: 11447540
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of disseminated intravascular coagulation with proteinase inhibitor].
    Okamoto K; Takeda S; Ohsato K
    Nihon Rinsho; 1991 Sep; 49(9):2130-5. PubMed ID: 1960878
    [No Abstract]   [Full Text] [Related]  

  • 20. [Disseminated intravascular coagulation in children. Therapeutic problems].
    Fiori GM; Murgia G; Targhetta R; Putzolu G; Biddau P
    Pediatr Med Chir; 1989; 11(5):491-4. PubMed ID: 2698466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.